PH-responsive polymer-drug conjugates: Design and progress

Journal of Controlled Release

Volumn 222, Issue , 2016, Pages 116-129

  Pang, Xin ^a   Jiang, Yue ^a   Xiao, Qicai ^a   Leung, Albert Wingnang ^a   Hua, Heyu ^a   Xu, Chuanshan ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Drug delivery system; pH responsive; Polymer drug conjugates; Tumor targeting

Indexed keywords

TUMORS;

CELLULAR INTERNALIZATION; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRICES; PH-RESPONSIVE; PH-RESPONSIVE POLYMER; POLYMER DRUGS; SYNTHESIS AND CHARACTERIZATIONS; TUMOR TARGETING;

POLYMERS;

HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; POLYMER; DRUG;

CHEMICAL BOND; CONJUGATE; CROSS LINKING; DISULFIDE BOND; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; PH; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; CHEMISTRY;

DRUG DELIVERY SYSTEMS; DRUG DESIGN; HYDROGEN-ION CONCENTRATION; PHARMACEUTICAL PREPARATIONS; POLYMERS;

EID: 84951866287     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.12.024     Document Type: Review

References (114)

1. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822
2. A. Bhardwaj, L. Kumar, S. Mehta, and A. Mehta Stimuli-sensitive systems-an emerging delivery system for drugs Artif. Cells Nanomed. Biotechnol. 1-12 2013
3. T. Volk, E. Jähde, H. Fortmeyer, K. Glüsenkamp, and M. Rajewsky pH in human tumour xenografts: effect of intravenous administration of glucose Br. J. Cancer 68 1993 492 500
4. P. Vaupel Tumor microenvironmental physiology and its implications for radiation oncology Semin. Radiat. Oncol. 2004 Elsevier 198 206
5. E. Yuba, A. Harada, Y. Sakanishi, and K. Kono Carboxylated hyperbranched poly (glycidol) s for preparation of pH-sensitive liposomes J. Control. Release 149 2011 72 80
6. E.A. Leite, C. dos Santos Giuberti, A.J. Wainstein, A.P.D. Wainstein, L.G. Coelho, Â.M. Lana, P.R. Savassi-Rocha, and M.C. De Oliveira Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration Life Sci. 84 2009 641 649
7. J. Liu, H. Li, X. Jiang, C. Zhang, and Q. Ping Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel Carbohydr. Polym. 82 2010 432 439
8. J.H. Kim, Y. Li, M.S. Kim, S.W. Kang, J.H. Jeong, and D.S. Lee Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers Int. J. Pharm. 427 2012 435 442
9. D. Prajakta, J. Ratnesh, K. Chandan, S. Suresh, S. Grace, V. Meera, and P. Vandana Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer J. Biomed. Nanotechnol. 5 2009 445 455
10. A. Makhlof, Y. Tozuka, and H. Takeuchi Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery Eur. J. Pharm. Sci. 42 2011 445 451
11. X. Zhang, K. Achazi, and R. Haag Boronate cross-linked ATP-and pH-responsive nanogels for intracellular delivery of anticancer drugs Adv. Healthc. Mater. 4 2015 585 592
12. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Design and engineering of nanogels for cancer treatment Drug Discov. Today 16 2011 457 463
13. E. Fleige, K. Achazi, K. Schaletzki, T. Triemer, and R. Haag pH-responsive dendritic core-multishell nanocarriers J. Control. Release 185 2014 99 108
14. Y. Gu, Y. Zhong, F. Meng, R. Cheng, C. Deng, and Z. Zhong Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy Biomacromolecules 14 2013 2772 2780
15. H. Maeda, T. Sawa, and T. Konno Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J. Control. Release 74 2001 47 61
16. X. Pang, X. Yang, and G. Zhai Polymer-drug conjugates: recent progress on administration routes Expert Opin. Drug Deliv. 11 2014 1075 1086
17. J. Kopeček, P. Kopečková, T. Minko, and Z.-R. Lu HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action Eur. J. Pharm. Biopharm. 50 2000 61 81
18. S.D. Conner, and S.L. Schmid Regulated Portals of Entry into the Cell 422 2003 37 44
19. R. Duncan, H. Cable, P. Rejmanová, J. Kopeček, and J. Lloyd Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl) methacrylamide copolymers Biochim. Biophys. Acta Gen. Subj. 799 1984 1 8
20. L.A. Mccormick, L.C. Seymour, R. Duncan, and J. Kopecek Interaction of a cationic N-(2-hydroxypropyl) methacrylamide copolymer with rat visceral yolk sacs cultured in vitro and rat liver in vivo J. Bioact. Compat. Polym. 1 1986 4 19
21. T. Lammers, W. Hennink, and G. Storm Tumour-targeted nanomedicines: principles and practice Br. J. Cancer 99 2008 392 397
22. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
23. K. Ulbrich, and V.R. Šubr Polymeric anticancer drugs with pH-controlled activation Adv. Drug Deliv. Rev. 56 2004 1023 1050
24. W.C. Shen, and H.J.P. Ryser cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate Biochem. Biophys. Res. Commun. 102 1981 1048 1054
25. A. Zachary pH-sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization Chem. Commun. 47 2011 4493 4495
26. E.R. Gillies, A.P. Goodwin, and J.M. Fréchet Acetals as pH-sensitive linkages for drug delivery Bioconjug. Chem. 15 2004 1254 1263
27. J.H. Park, Y.W. Cho, Y.J. Son, K. Kim, H. Chung, S.Y. Jeong, K. Choi, C.R. Park, R.-W. Park, and I.-S. Kim Preparation and characterization of self-assembled nanoparticles based on glycol chitosan bearing adriamycin Colloid Polym. Sci. 284 2006 763 770
28. F.-Q. Hu, L.-N. Liu, Y.-Z. Du, and H. Yuan Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles Biomaterials 30 2009 6955 6963
29. H.S. Yoo, E.A. Lee, and T.G. Park Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages J. Control. Release 82 2002 17 27
30. S. Zhu, M. Hong, G. Tang, L. Qian, J. Lin, Y. Jiang, and Y. Pei Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style Biomaterials 31 2010 1360 1371
31. X. Ke, D.J. Coady, C. Yang, A.C. Engler, J.L. Hedrick, and Y.Y. Yang pH-sensitive polycarbonate micelles for enhanced intracellular release of anticancer drugs: a strategy to circumvent multidrug resistance Polym. Chem. 5 2014 2621 2628
32. J. Zou, F. Zhang, S. Zhang, S.F. Pollack, M. Elsabahy, J. Fan, and K.L. Wooley Poly (ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery Adv. Healthc. Mater. 3 2014 441 448
33. V.F. Patel, J.N. Hardin, J.M. Mastro, K.L. Law, J.L. Zimmermann, W.J. Ehlhardt, J.M. Woodland, and J.J. Starling Novel acid labile COL1 trityl-linked difluoronucleoside immunoconjugates: synthesis, characterization, and biological activity1 Bioconjug. Chem. 7 1996 497 510
34. V.F. Patel, J.N. Hardin, G.B. Grindey, and R.M. Schultz Tritylated oncolytics as prodrugs Bioorg. Med. Chem. Lett. 5 1995 513 518
35. J. Cui, Y. Yan, Y. Wang, and F. Caruso Templated assembly of pH-labile polymer-drug particles for intracellular drug delivery Adv. Funct. Mater. 22 2012 4718 4723
36. O. Sedláček, M. Hrubý, M. Studenovský, D. Větvička, J. Svoboda, D. Kaňková, J. Kovář, and K. Ulbrich Polymer conjugates of acridine-type anticancer drugs with pH-controlled activation Biorg. Med. Chem. 20 2012 4056 4063
37. D. Pan, C. Guo, K. Luo, Q. Yi, and Z. Gu PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy Biomaterials 35 2014 10080 10092
38. X. Hu, S. Liu, Y. Huang, X. Chen, and X. Jing Biodegradable block copolymer-doxorubicin conjugates via different linkages: preparation, characterization, and in vitro evaluation Biomacromolecules 11 2010 2094 2102
39. X. Guan, X. Hu, S. Liu, Y. Huang, X. Jing, and Z. Xie Cyclic RGD targeting nanoparticles with pH sensitive polymer-drug conjugates for effective treatment of melanoma RSC Adv. 4 2014 55187 55194
40. D.W. Dong, S.W. Tong, and X.R. Qi Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers J Biomed. Mater. Res. 101 2013 1336 1344
41. X.-B. Xiong, Z. Ma, R. Lai, and A. Lavasanifar The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin Biomaterials 31 2010 757 768
42. X. Guo, C. Shi, J. Wang, S. Di, and S. Zhou pH-triggered intracellular release from actively targeting polymer micelles Biomaterials 34 2013 4544 4554
43. K. Ulbrich, T. Etrych, P. Chytil, M. JelInková, and B. Říhová HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity J. Control. Release 87 2003 33 47
44. O. Sedláček, M. Studenovský, D. Větvička, K. Ulbrich, and M. Hrubý Fine tuning of the pH-dependent drug release rate from polyHPMA-ellipticinium conjugates Biorg. Med. Chem. 21 2013 5669 5672
45. T.S. Etrych, M. Šírová, L. Starovoytova, B. Říhová, and K. Ulbrich HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release Mol. Pharm. 7 2010 1015 1026
46. T. Etrych, P. Chytil, M. Jelínková, B. Říhová, and K. Ulbrich Synthesis of HPMA copolymers containing doxorubicin bound via a hydrazone linkage. Effect of spacer on drug release and in vitro cytotoxicity Macromol. Biosci. 2 2002 43 52
47. P. Chytil, T. Etrych, Č. Koňák, M. Šírová, T. Mrkvan, B. Říhová, and K. Ulbrich Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification J. Control. Release 115 2006 26 36
48. T. Minko, P. Kopečková, and J. Kopeček Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells Pharm. Res. 16 1999 986 996
49. O. Hovorka, M. Št'astný, T. Etrych, V. Šubr, J. Strohalm, K. Ulbrich, and B. ŘIhová Differences in the intracellular fate of free and polymer-bound doxorubicin J. Control. Release 80 2002 101 117
50. T. Etrych, V. Šubr, J. Strohalm, M. Šírová, B. Říhová, and K. Ulbrich HPMA copolymer-doxorubicin conjugates: the effects of molecular weight and architecture on biodistribution and in vivo activity J. Control. Release 164 2012 346 354
51. H. Pan, M. Sima, J. Yang, and J. Kopeček Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy Macromol. Biosci. 13 2013 155 160
52. W.-M. Choi, P. Kopečková, T. Minko, and J. Kopeček Synthesis of HPMA copolymer containing adriamycin bound via an acid-labile spacer and its activity toward human ovarian carcinoma cells J. Bioact. Compat. Polym. 14 1999 447 456
53. P. Chytil, T. Etrych, J. Kříž, V. Šubr, and K. Ulbrich N-(2-Hydroxypropyl) methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation Eur. J. Pharm. Sci. 41 2010 473 482
54. A.W. Alani, Y. Bae, D.A. Rao, and G.S. Kwon Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel Biomaterials 31 2010 1765 1772
55. X. Hu, R. Wang, J. Yue, S. Liu, Z. Xie, and X. Jing Targeting and anti-tumor effect of folic acid-labeled polymer-doxorubicin conjugates with pH-sensitive hydrazone linker J. Mater. Chem. 22 2012 13303 13310
56. D. Vetvicka, M. Hruby, O. Hovorka, T. Etrych, M. Vetrik, L. Kovar, M. Kovar, K. Ulbrich, and B. Rihova Biological evaluation of polymeric micelles with covalently bound doxorubicin Bioconjug. Chem. 20 2009 2090 2097
57. Y. Wang, X. Zhang, Z. Xu, H. Huang, Y. Li, and J. Wang A pH-sensitive theranostics system based on doxorubicin conjugated with the comb-shaped polymer coating of quantum dots J. Mater. Chem. 49 2014 7539 7546
58. L. Deng, H. Dong, A. Dong, and J. Zhang A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity Eur. J. Pharm. Biopharm. 97 2015 107 117
59. H. Lage An overview of cancer multidrug resistance: a still unsolved problem Cell. Mol. Life Sci. 65 2008 3145 3167
60. F. Greco, and M.J. Vicent Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines Adv. Drug Deliv. Rev. 61 2009 1203 1213
61. E.S. Lee, K. Na, and Y.H. Bae Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor J. Control. Release 103 2005 405 418
62. M.E. Davis, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
63. V. Omelyanenko, P. Kopečková, C. Gentry, and J. Kopeček Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate J. Control. Release 53 1998 25 37
64. T. Minko, P. Kopečková, and J. Kopeček Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma Int. J. Cancer 86 2000 108 117
65. J. Kopeček Polymer-drug conjugates: origins, progress to date and future directions Adv. Drug Deliv. Rev. 65 2013 49 59
66. Q. He, Y. Gao, L. Zhang, Z. Zhang, F. Gao, X. Ji, Y. Li, and J. Shi A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance Biomaterials 32 2011 7711 7720
67. E.S. Lee, K. Na, and Y.H. Bae Super pH-sensitive multifunctional polymeric micelle Nano Lett. 5 2005 325 329
68. Y. Yu, C.-K. Chen, W.-C. Law, E. Weinheimer, S. Sengupta, P.N. Prasad, and C. Cheng Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery Biomacromolecules 15 2014 524 532
69. S. McRae Page, E. Henchey, X. Chen, S. Schneider, and T. Emrick Efficacy of polyMPC-DOX prodrugs in 4 T1 tumor-bearing mice Mol. Pharm. 11 2014 1715 1720
70. X. Duan, J. Xiao, Q. Yin, Z. Zhang, H. Yu, S. Mao, and Y. Li Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram ACS Nano 7 2013 5858 5869
71. F.M. Veronese PEGylated Protein Drugs: Basic Science and Clinical Applications 2009 Birkhauser Basel, Switzerland
72. R. Duncan, and S.C. Richardson Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges Mol. Pharm. 9 2012 2380 2402
73. H. Zhang, F. Li, J. Yi, C. Gu, L. Fan, Y. Qiao, Y. Tao, C. Cheng, and H. Wu Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery Eur. J. Pharm. Sci. 42 2011 517 526
74. H. Li, S. Bian, Y. Huang, J. Liang, Y. Fan, and X. Zhang High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting J. Biomed. Mater. Res. 102 2014 150 159
75. H. Li, Y. Cui, J. Sui, S. Bian, Y. Sun, J. Liang, Y. Fan, and X. Zhang Efficient delivery of DOX to nuclei of hepatic carcinoma cells in the subcutaneous tumor model using pH-sensitive pullulan-DOX conjugates ACS Appl. Mater. Interfaces 7 2015 15855 15865
76. S. Cai, S. Thati, T.R. Bagby, H.M. Diab, N.M. Davies, M.S. Cohen, and M.L. Forrest Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer J. Control. Release 146 2010 212 218
77. K. Jain, P. Kesharwani, U. Gupta, and N. Jain Dendrimer toxicity: let's meet the challenge Int. J. Pharm. 394 2010 122 142
78. S. Xu, Y. Luo, R. Graeser, A. Warnecke, F. Kratz, P. Hauff, K. Licha, and R. Haag Development of pH-responsive core-shell nanocarriers for delivery of therapeutic and diagnostic agents Bioorg. Med. Chem. Lett. 19 2009 1030 1034
79. S. Zhu, M. Hong, L. Zhang, G. Tang, Y. Jiang, and Y. Pei PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation Pharm. Res. 27 2010 161 174
80. Y. Chang, X. Meng, Y. Zhao, K. Li, B. Zhao, M. Zhu, Y. Li, X. Chen, and J. Wang Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs) J. Colloid Interface Sci. 363 2011 403 409
81. X. Li, M. Takashima, E. Yuba, A. Harada, and K. Kono PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy Biomaterials 35 2014 6576 6584
82. K. Luo, C. Li, G. Wang, Y. Nie, B. He, Y. Wu, and Z. Gu Peptide dendrimers as efficient and biocompatible gene delivery vectors: synthesis and in vitro characterization J. Control. Release 155 2011 77 87
83. K. Luo, B. He, Y. Wu, Y. Shen, and Z. Gu Functional and biodegradable dendritic macromolecules with controlled architectures as nontoxic and efficient nanoscale gene vectors Biotechnol. Adv. 32 2014 818 830
84. W. She, K. Luo, C. Zhang, G. Wang, Y. Geng, L. Li, B. He, and Z. Gu The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy Biomaterials 34 2013 1613 1623
85. W. She, N. Li, K. Luo, C. Guo, G. Wang, Y. Geng, and Z. Gu Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy Biomaterials 34 2013 2252 2264
86. T. Etrych, L. Kovář, J. Strohalm, P. Chytil, B. Říhová, and K. Ulbrich Biodegradable star HPMA polymer-drug conjugates: biodegradability, distribution and anti-tumor efficacy J. Control. Release 154 2011 241 248
87. M. Calderón, P. Welker, K. Licha, I. Fichtner, R. Graeser, R. Haag, and F. Kratz Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly (ethylene glycol) shell J. Control. Release 151 2011 295 301
88. S. Lee, K. Saito, H.-R. Lee, M.J. Lee, Y. Shibasaki, Y. Oishi, and B.-S. Kim Hyperbranched double hydrophilic block copolymer micelles of poly (ethylene oxide) and polyglycerol for pH-responsive drug delivery Biomacromolecules 13 2012 1190 1196
89. W. Xu, I.A. Siddiqui, M. Nihal, S. Pilla, K. Rosenthal, H. Mukhtar, and S. Gong Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer Biomaterials 34 2013 5244 5253
90. Y. Xiao, H. Hong, A. Javadi, J.W. Engle, W. Xu, Y. Yang, Y. Zhang, T.E. Barnhart, W. Cai, and S. Gong Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging Biomaterials 33 2012 3071 3082
91. M. Prabaharan, J.J. Grailer, S. Pilla, D.A. Steeber, and S. Gong Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery Biomaterials 30 2009 6065 6075
92. H. Yuan, K. Luo, Y. Lai, Y. Pu, B. He, G. Wang, Y. Wu, and Z. Gu A novel poly (l-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions Mol. Pharm. 7 2010 953 962
93. M. Talelli, M. Barz, C.J. Rijcken, F. Kiessling, W.E. Hennink, and T. Lammers Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation Nano Today 10 2015 93 117
94. M. Talelli, M. Iman, A.K. Varkouhi, C.J. Rijcken, R.M. Schiffelers, T. Etrych, K. Ulbrich, C.F. van Nostrum, T. Lammers, and G. Storm Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin Biomaterials 31 2010 7797 7804
95. S. Aryal, C.-M.J. Hu, and L. Zhang Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery ACS Nano 4 2009 251 258
96. M. Li, Z. Tang, S. Lv, W. Song, H. Hong, X. Jing, Y. Zhang, and X. Chen Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin Biomaterials 35 2014 3851 3864
97. Z. Jia, L. Wong, T.P. Davis, and V. Bulmus One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid-and reductant-sensitive crosslinked micelles Biomacromolecules 9 2008 3106 3113
98. C. Wei, J. Guo, and C. Wang Dual stimuli-responsive polymeric micelles exhibiting "AND" logic gate for controlled release of adriamycin Macromol. Rapid Commun. 32 2011 451 455
99. F. Meng, W.E. Hennink, and Z. Zhong Reduction-sensitive polymers and bioconjugates for biomedical applications Biomaterials 30 2009 2180 2198
100. M. Talelli, K. Morita, C. Rijcken, R. Aben, T. Lammers, H. Scheeren, C. Van Nostrum, G. Storm, and W. Hennink Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry Bioconjug. Chem. 22 2011 2519 2530
101. F. Zhan, W. Chen, Z. Wang, W. Lu, R. Cheng, C. Deng, F. Meng, H. Liu, and Z. Zhong Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release Biomacromolecules 12 2011 3612 3620
102. X. Zhang, K. Achazi, D. Steinhilber, F. Kratz, J. Dernedde, and R. Haag A facile approach for dual-responsive prodrug nanogels based on dendritic polyglycerols with minimal leaching J. Control. Release 174 2014 209 216
103. R. Liang, M. Wei, D.G. Evans, and X. Duan Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics Chem. Commun. 50 2014 14071 14081
104. Y.J. Gu, J. Cheng, J. Jin, S.H. Cheng, and W.-T. Wong Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells Int. J. Nanomedicine 6 2011 2889 2898
105. G. Kandasamy, and D. Maity Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics Int. J. Pharm. 2015 (in press)
106. 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging Biomaterials 32 2011 4151 4160
107. Y. Xiao, H. Hong, V.Z. Matson, A. Javadi, W. Xu, Y. Yang, Y. Zhang, J.W. Engle, R.J. Nickles, and W. Cai Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging Theranostics 2 2012 757 768
108. K.Y. Lee, Y. Wang, and S. Nie In vitro study of a pH-sensitive multifunctional doxorubicin-gold nanoparticle system: therapeutic effect and surface enhanced Raman scattering RSC Adv. 5 2015 65651 65659
109. C.H. Lee, S.H. Cheng, I. Huang, J.S. Souris, C.S. Yang, C.Y. Mou, and L.W. Lo Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics Angew. Chem. 122 2010 8390 8395
110. I.-P. Huang, S.-P. Sun, S.-H. Cheng, C.-H. Lee, C.-Y. Wu, C.-S. Yang, L.-W. Lo, and Y.-K. Lai Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance Mol. Cancer Ther. 10 2011 761 769
111. J.E. Lee, D.J. Lee, N. Lee, B.H. Kim, S.H. Choi, and T. Hyeon Multifunctional mesoporous silica nanocomposite nanoparticles for pH controlled drug release and dual modal imaging J. Mater. Chem. 21 2011 16869 16872
112. T. Zhang, Z. Ding, H. Lin, L. Cui, C. Yang, X. Li, H. Niu, N. An, R. Tong, and F. Qu pH-sensitive gold nanorods with a mesoporous silica shell for drug release and photothermal therapy Eur. J. Inorg. Chem. 2015 2015 2277 2284
113. H. He, H. Xiao, H. Kuang, Z. Xie, X. Chen, X. Jing, and Y. Huang Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery Colloid. Surf. B 117 2014 75 81
114. A. Hinton, S.R. Sennoune, S. Bond, M. Fang, M. Reuveni, G.G. Sahagian, D. Jay, R. Martinez-Zaguilan, and M. Forgac Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells J. Biol. Chem. 284 2009 16400 16408